Related Experiment Video
Updated: Jul 20, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 9, 2011
Soft tissue infections in children: a retrospective analysis of 242 hospitalized patients
Gonul Tanir1, Alparslan Tonbul, Nilden Tuygun
1Department of Pediatrics, Dr. Sami Ulus Children's Health and Diseases Training and Research Center, Ankara, Turkey. gonultanir58@yahoo.com
Insights
Pediatric soft tissue infections (STIs) are common, often requiring antibiotics. This study analyzed 242 children, finding cellulitis most frequent and identifying common treatments and outcomes.
Area of Science:
- Pediatrics
- Infectious Diseases
- Antimicrobial Therapy
Background:
- Pediatric soft tissue infections (STIs) are a frequent reason for antimicrobial therapy in children.
- Understanding the epidemiology and management of STIs is crucial for effective treatment.
Purpose of the Study:
- To retrospectively analyze the characteristics, treatment, and outcomes of pediatric patients hospitalized with soft tissue infections.
- To identify common pathogens, predisposing factors, and therapeutic strategies for STIs in a pediatric population.
Main Methods:
- Retrospective analysis of 242 pediatric patients hospitalized with STIs between January 2000 and January 2004.
- Data collected included patient demographics, STI type, predisposing factors, microbiological findings, antimicrobial therapy, surgical interventions, and clinical outcomes.
- Analysis of inflammatory markers (white blood cell count, C-reactive protein, erythrocyte sedimentation rate) and duration of antibiotic therapy.
Main Results:
- Cellulitis was the most common STI (39.7%), followed by cervical lymphadenitis (25.6%) and cervical abscess (20.2%).
- Predisposing factors were identified in 42.2% of patients; Staphylococcus aureus and Streptococcus pyogenes were common pathogens.
- Initial antibiotic choices included ampicillin/sulbactam (68.6%), ceftriaxone/cefotaxime (24.0%), and ceftriaxone plus clindamycin (7.4%). Surgical drainage was performed in 86.7% of abscess cases.
- Mean duration of parenteral antibiotic therapy was 10 days, influenced by admission inflammatory marker levels. Complications occurred in 4.8% of patients, with no mortality.
Conclusions:
- Pediatric soft tissue infections encompass a range of conditions, with cellulitis being most prevalent.
- Effective management involves appropriate antimicrobial therapy, often combined with surgical intervention for abscesses.
- Treatment duration and outcomes are influenced by initial disease severity and inflammatory markers, highlighting the need for tailored therapeutic approaches.
Abstract:
Pediatric soft tissue infections (STIs) are frequently seen disorders that represent one of the most common indications for antimicrobial therapy. We conducted a retrospective analysis of 242 patients who were hospitalized with STIs during the period from January 2000 to January 2004. The ages of the patients ranged from 1 month to 180 months (mean 44.33 +/- 36.92 months). The STIs were distributed as cellulitis in 96 (39.7%) patients, cervical lymphadenitis in 62 (25.6%), cervical abscess in 49 (20.2%), subcutaneous abscess in 25 (10.3%), pyomyositis in 6 (2.5%) and necrotizing fasciitis in 4 (1.6%). In 103 (42.2%) patients, a predisposing factor was found. Blood cultures yielded positive results in 18 (7.4%) cases. The responsible microorganisms were identified in 74 (30.6%) patients. The initial therapy consisted of ampicillin/sulbactam in 166 (68.6%) patients, ceftriaxone or cefotaxime in 58 (24.0%), and ceftriaxone plus clindamycin in 18 (7.4%). Surgical drainage was performed in 65 (86.7%) patients with abscesses. White blood cell count, C-reactive protein, and erythrocyte sedimentation rate returned to normal in mean periods of 3, 7 and 10 days, respectively. The mean duration of parenteral antibiotic therapy was 10 days, and the duration of treatment was found to increase with increasing C-reactive protein and erythrocyte sedimentation rate on admission (P = 0.001 and P < 0.001). Complications developed in 12 (4.8%) patients; there was no mortality.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Tonsillitis II: Management
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Urinary Tract Infection II: Pathophysiology